Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2026-04-20 @ 4:00 PM
Study NCT ID:
NCT02231268
Status:
COMPLETED
Last Update Posted:
2014-09-04
First Post:
2014-09-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study to Assess a 6-months Treatment With Gladem
Sponsor:
Boehringer Ingelheim
Organization:
Study Overview
Official Title:
Observational Study Via Internet to Assess a 6-months Treatment With GLADEM
Status:
COMPLETED
Status Verified Date:
2014-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
* Evaluation of a 6-months treatment with Gladem
* Experiences with the internet for performing a postmarketing study (PMS) trial
* Experiences with the internet for performing a postmarketing study (PMS) trial
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: